Search Results
Impact
Ulipristal Acetate
April 11, 2016
Impact
Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
April 04, 2016
Event
Southeast Regional Meeting of the American Chemical Society 2023 Annual Meeting
October 25, 2023
Expert
Gabriel A. Knudsen
Focus Area
Preventing Substance Use
News Release
RTI International Licenses Portfolio of Compounds to APIE Therapeutics
August 25, 2020
Impact
Novel Solutions: The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)
September 26, 2022
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 14, 2019 - The Telegraph
Expert
Kenneth Rehder
Expert
Chunyang Jin
Impact
An Alternative to Opioids: Targeting Cannabinoid Receptors for Relief of Neuropathic Pain
September 18, 2017
Focus Area
Substance Use Research
Announcement
New Paper Describes Accurate, Scalable Method for Detecting Fragile X Syndrome in Newborns
March 05, 2020
Announcement
RTI Secures Chemistry Center for Combating Antibiotic Resistance (CC4CARB) Contract from National Institute of Allergy and Infectious Diseases to Address Bottlenecks in Early Antibiotic Drug Discovery
April 16, 2021
Expert
Jeffrey Ambroso
Expert